Presents Three Abstracts for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ECCO NANTES, France - ...
The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
Now, a study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in the next five ...
Session: Poster and Exhibition Hall Reception Poster Title:PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS ...
On Jan. 28, 2024, a freezing-cold night in New York, Kevin Eriksen made a commitment to himself: He was going to walk ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
A new method for detecting bowel cancer is more than 90% accurate at predicting which higher risk people will develop the ...
Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer - Doctors believe new test could lead ...
For decades, people in this area have been dealing with unusually high rates of serious health problems, such as multiple sclerosis, ulcerative colitis, Crohn’s disease, and various ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback